Aniket Satale
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aniket Satale has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Asif Dabeer Jafri
Department of Emergency Medicine and Tele-ICU Service, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh
2 shared publications - Aarti Sagar
Department of Internal Medicine, M. L. B. Medical College, Jhansi, Uttar Pradesh
1 shared publication - Kayenaat Rizvi
Department of Forensic Medicine, ERA’s Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh
1 shared publication - Muktesh Singh
Department of Anesthesiology, MLN Medical College, Prayagraj, Uttar Pradesh, India
1 shared publication - Om Prakash Sanjeev
Department of Emergency Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
1 shared publication - Ratender Kumar Singh
Department of Emergency Medicine, Telemedicine and Digital Health, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh
1 shared publication
Latest Publications
- Open Access
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4) , 898–905
A retrospective study on sickle cell disease-associated cardiovascular anomalies
Introduction and aim. Sickle cell disease (SCD), a chronic inherited hemolytic disorder prevalent in certain regions of India and globally, is associated with various cardiovascular complications that significantly impact morbidity and mortality. The objective is to assess the relationship among clinical, electrocardiographic, and echocardiographic findings in individuals diagnosed with sickle cell disease, and, as a secondary aim, to contrast these findings with those observed in patients with SCTtaking into account different age groups across both sexes. Material and methods. This study included thirty-four individuals previously diagnosed with sickle cell disease or SCTbased on hemoglobin electrophoresis. Clinical records were reviewed to obtain data from comprehensive examinations, including electrocardiographic and echocardiographic assessments. Cardiac function was evaluated, interpreted, and compared between the two groups using documented ECG and echocardiography results. Results. A total of 34 participants were enrolled, including 23 individuals with SCD and 11 with sickle cell trait (SCT). The mean age was 28.6±9.3 years in the SCD group and 30.2±8.7 years in the SCT group (p=0.57). Males predominated in both groups (SCD: 65.2%; SCT: 63.6%). Clinical examination revealed a statistically significant higher frequency of displaced apex beat in the SCD group (60.9%) compared to SCT (18.2%) (p=0.03). Electrocardiographic abnormalities such as left ventricular hypertrophy were more common in SCD (47.8%) than SCT (18.2%) (p=0.04). ST-T changes were seen in 56.5% of SCD vs. 9.1% of SCT (p=0.01). Echocardiographic findings demonstrated significantly elevated pulmonary artery systolic pressure (PASP) in the SCD group (38.6±6.2 mmHg) compared to SCT (28.4±5.7 mmHg) (p < 0.001). Mean pulmonary artery pressure (mPAP) was also higher in SCD (25.3±4.8 mmHg) vs. SCT (19.2±3.9 mmHg) (p=0.002). Tricuspid regurgitation velocity (TRV) was elevated in SCD (2.9±0.3 m/s) compared to SCT (2.4±0.2 m/s) (p=0.001). Right ventricular dilatation and diastolic dysfunction were noted in 39.1% and 34.8% of SCD cases, respectively, while absent in SCT (p<0.05 for both). In univariate logistic regression, apex beat displacement (OR=4.6; p=0.04), elevated PASP (OR=5.2; p=0.01), increased mPAP (OR=4.3; p=0.02), and TRV (OR=6.1; p=0.009) were significant predictors of SCD. Multivariate logistic regression identified PASP as an independent predictor of SCD (OR=4.8; 95% CI: 1.3‒17.9; p=0.02). Conclusion. The findings highlight that patients with sickle cell disease exhibit a significantly higher burden of cardiac abnormalities than those with sickle cell trait. Among the evaluated parameters, pulmonary artery systolic pressure emerged as an independent predictor of sickle cell disease.
- 30 December 2025
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 23 (4) , 898–905
Open AccessA retrospective study on sickle cell disease-associated cardiovascular anomalies
Introduction and aim. Sickle cell disease (SCD), a chronic inherited hemolytic disorder prevalent in certain regions of India and globally, is associated with various cardiovascular complications that significantly impact morbidity and mortality. The objective is to assess the relationship among clinical, electrocardiographic, and echocardiographic findings in individuals diagnosed with sickle cell disease, and, as a secondary aim, to contrast these findings with those observed in patients with SCTtaking into account different age groups across both sexes. Material and methods. This study included thirty-four individuals previously diagnosed with sickle cell disease or SCTbased on hemoglobin electrophoresis. Clinical records were reviewed to obtain data from comprehensive examinations, including electrocardiographic and echocardiographic assessments. Cardiac function was evaluated, interpreted, and compared between the two groups using documented ECG and echocardiography results. Results. A total of 34 participants were enrolled, including 23 individuals with SCD and 11 with sickle cell trait (SCT). The mean age was 28.6±9.3 years in the SCD group and 30.2±8.7 years in the SCT group (p=0.57). Males predominated in both groups (SCD: 65.2%; SCT: 63.6%). Clinical examination revealed a statistically significant higher frequency of displaced apex beat in the SCD group (60.9%) compared to SCT (18.2%) (p=0.03). Electrocardiographic abnormalities such as left ventricular hypertrophy were more common in SCD (47.8%) than SCT (18.2%) (p=0.04). ST-T changes were seen in 56.5% of SCD vs. 9.1% of SCT (p=0.01). Echocardiographic findings demonstrated significantly elevated pulmonary artery systolic pressure (PASP) in the SCD group (38.6±6.2 mmHg) compared to SCT (28.4±5.7 mmHg) (p < 0.001). Mean pulmonary artery pressure (mPAP) was also higher in SCD (25.3±4.8 mmHg) vs. SCT (19.2±3.9 mmHg) (p=0.002). Tricuspid regurgitation velocity (TRV) was elevated in SCD (2.9±0.3 m/s) compared to SCT (2.4±0.2 m/s) (p=0.001). Right ventricular dilatation and diastolic dysfunction were noted in 39.1% and 34.8% of SCD cases, respectively, while absent in SCT (p<0.05 for both). In univariate logistic regression, apex beat displacement (OR=4.6; p=0.04), elevated PASP (OR=5.2; p=0.01), increased mPAP (OR=4.3; p=0.02), and TRV (OR=6.1; p=0.009) were significant predictors of SCD. Multivariate logistic regression identified PASP as an independent predictor of SCD (OR=4.8; 95% CI: 1.3‒17.9; p=0.02). Conclusion. The findings highlight that patients with sickle cell disease exhibit a significantly higher burden of cardiac abnormalities than those with sickle cell trait. Among the evaluated parameters, pulmonary artery systolic pressure emerged as an independent predictor of sickle cell disease.
- Open Access
- 4 September 2025
- Published by PAGEPress Publications in Emergency Care Journal
- Vol. 21 (4)
Emerging management strategies for aluminum phosphide poisoning
Aluminum Phosphide (AlP), commonly known as Celphos in India, is a highly toxic pesticide used for grain preservation. Upon contact with moisture, it releases Phosphine gas (PH₃), leading to mitochondrial dysfunction, oxidative stress, and multi-organ failure. With no specific antidote available, AlP poisoning carries a high mortality rate, necessitating prompt life-supportive care. The aim was to evaluate the effectiveness of early gastric lavage with coconut oil and sodium bicarbonate (SBC), combined with antioxidant therapy, in improving survival outcomes in severe AlP poisoning. This retrospective study analyzed clinical cases of AlP poisoning involving the ingestion of 3 to 9 grams of AlP tablets. All patients underwent early gastric lavage within 6 hours of ingestion and received antioxidants (Vitamin E, Glutathione, N-acetylcysteine ), and supportive therapy, including vasopressors and peritoneal dialysis as needed. All patients presented with severe hypotension, metabolic acidosis, and multi-organ dysfunction. Despite presenting in critical condition, three patients survived and one patient succumbed, indicating favorable outcomes following treatment. Early gastric decontamination with coconut oil and sodium bicarbonate (SBC), supplemented by antioxidant therapy, shows promise in reducing mortality in AlP poisoning. Further studies are needed to establish standardized treatment protocols.
- 4 September 2025
- Published by PAGEPress Publications in Emergency Care Journal
- Vol. 21 (4)
Open AccessEmerging management strategies for aluminum phosphide poisoning
Aluminum Phosphide (AlP), commonly known as Celphos in India, is a highly toxic pesticide used for grain preservation. Upon contact with moisture, it releases Phosphine gas (PH₃), leading to mitochondrial dysfunction, oxidative stress, and multi-organ failure. With no specific antidote available, AlP poisoning carries a high mortality rate, necessitating prompt life-supportive care. The aim was to evaluate the effectiveness of early gastric lavage with coconut oil and sodium bicarbonate (SBC), combined with antioxidant therapy, in improving survival outcomes in severe AlP poisoning. This retrospective study analyzed clinical cases of AlP poisoning involving the ingestion of 3 to 9 grams of AlP tablets. All patients underwent early gastric lavage within 6 hours of ingestion and received antioxidants (Vitamin E, Glutathione, N-acetylcysteine ), and supportive therapy, including vasopressors and peritoneal dialysis as needed. All patients presented with severe hypotension, metabolic acidosis, and multi-organ dysfunction. Despite presenting in critical condition, three patients survived and one patient succumbed, indicating favorable outcomes following treatment. Early gastric decontamination with coconut oil and sodium bicarbonate (SBC), supplemented by antioxidant therapy, shows promise in reducing mortality in AlP poisoning. Further studies are needed to establish standardized treatment protocols.